InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Tuesday, 06/20/2017 3:22:08 PM

Tuesday, June 20, 2017 3:22:08 PM

Post# of 7536
SPEX unusual volume, Spherix Inc. Announces Definitive Terms Reached to Acquire Controlling Interest in Hoth Therapeutics, a Biopharmaceutical Company Developing its BioLexa Platform to Treat Skin Illness Such as Eczema. https://stocknewsnow.com/companynews/7522100922580145/SPEX/101843

4.9m O/S. the balance sheet is solid. tiny debt. assets/liabilities ratio=2.

10Q: http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12064476

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.